Announcements

Intimation of Schedule of Investor Conference

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we would wish to inform you that the Senior Management of the Company will be participating at the ‘JP Morgan, 2018 India Investor Summit’ to be held at New Delhi on September 19, 2018 and September 20, 2018.

Download: Gsk Jp Morgan Conference September 19 20 2018 - (PDF 183 KB)

Closure of “Trading Window”

In accordance with the Company’s Policy on Insider Trading, the date of commencement of closing of “Trading Window” shall be from September 15, 2018 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the Second Quarter and Half Year ended September 30, 2018.

Download: Gsk Trading Window Closure September 2018 - (PDF 244 KB)

Notice of Book Closure and Record Date

The Register of Members and Share Transfer Book of the Company will remain closed from Thursday, August 2, 2018 to Wednesday, August 8, 2018 (both days inclusive) for the purpose of 59th Annual General Meeting and for taking on record the Shareholders for the purpose of payment of Dividend, if approved at the Annual General Meeting, for the year ended March 31, 2018.

Dividend, if approved at the Annual General Meeting, will be paid to all those Members whose names appear in the Company’s Register of Members and to those persons whose names appear as beneficial owner (as per the details to be furnished by the Depositories in respect of shares held in dematerialized form) as at the close of business hours on Wednesday, August 1, 2018.

Intimation of Board Meeting

A meeting of the Board of Directors of the Company will be held on Tuesday, August 7, 2018 at 18:00 hours at Conference Room, GlaxoSmithKline Consumer Healthcare Limited, Patiala Road, Nabha -147201 to, inter-alia, consider and take on record the unaudited Financial Results for the quarter ended June 30, 2018 with Limited Review by Auditors.

Change in Directorate

Mr. Zubair Ahmed has stepped down as Director and Non-Executive Chairman of the Board of the Company on June 30, 2018. Mr. P. Dwarakanath has been nominated as the “Non-Executive Chairman Designate” of the Board of the Company and will take over as the Non-Executive Chairman of the Board with effect from July 1, 2018

3 May 2018

A meeting of the Board of Directors of the Company will be held on Friday, May 11, 2018 at 01:00 p.m. at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Centre, DLF Phase – V, Golf Course Road, Gurugram 122 002 to, inter alia, consider and take on record the Audited Financial Results for the financial year ended March 31, 2018 and to consider Dividend for the financial year ended March 31, 2018.

5 February 2018

Board Meeting

A meeting of the Board of Directors of the Company will be held on Monday, 12 February ,2018 at 02:00 p.m. at the Corporate Office of the Company situated at 24th & 25th Floor, One Horizon Center, DLF Phase – V, Golf Course Road, Gurugram 122002 to, inter-alia, consider and take on record the unaudited Financial Results for the quarter ended December 31, 2017 with Limited Review by Auditors.

06-Dec-2017

Change in Directorate

Mr. Navneet Saluja has been appointed as the Managing Director of the Company with effect from January 1, 2018 in place of Mr. Manoj Kumar who ceases to be the Managing Director from the close of business of December 31, 2017.

Mr. Subodh Bhargava would step down as Director and Non-Executive Chairman of the Board of the Company on completion of his tenure on March 31, 2018. Mr. Zubair Ahmed has been nominated as the “Non-Executive Chairman Designate” of the Board of the Company and will take over as the Non-Executive Chairman of the Board with effect from April 1, 2018.